Carborane-Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index

  • 0Centre for Biotechnology and Biomedicine (BBZ), Faculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität Leipzig, Deutscher Platz 5, 04103, Leipzig, Germany.

|

|

Summary

This summary is machine-generated.

Novel carborane analogs of flurbiprofen and celecoxib were synthesized and evaluated for cyclooxygenase (COX) inhibition. Nido-carborane derivatives showed enhanced potency, with compound 10 exhibiting sub-micromolar COX-2 inhibition.

Area Of Science

  • Medicinal Chemistry
  • Pharmacology
  • Organic Synthesis

Background

  • Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, are key in prostaglandin synthesis.
  • COX-2 overexpression is linked to inflammation, cancer, and neurodegenerative diseases, driving the need for selective inhibitors.
  • Current nonsteroidal anti-inflammatory drugs (NSAIDs) often lack selectivity, leading to side effects.

Purpose Of The Study

  • To synthesize and characterize novel carborane analogs of flurbiprofen and celecoxib.
  • To evaluate the in vitro inhibitory activity and selectivity of these analogs against COX-1 and COX-2.
  • To explore the potential of carboranes as hydrophobic substituents for enhancing COX-2 selectivity.

Main Methods

  • Synthesis and characterization of eight flurbiprofen- and celecoxib-based carborane derivatives (four ortho- and four nido-carboranes).
  • In vitro biological evaluation of inhibitory efficacy against purified COX-1 and COX-2 enzymes.
  • Determination of IC50 values and selectivity profiles for the synthesized compounds.

Main Results

  • Nido-carborane derivatives demonstrated significantly higher potency compared to their closo-carborane counterparts.
  • Celecoxib-based nido-carborane compound 10 achieved sub-micromolar IC50 for COX-2 with slight selectivity.
  • Flurbiprofen-based nido-carborane derivatives 14a and 14b showed improved activity over existing carborane analogs.

Conclusions

  • Carboranes can serve as effective hydrophobic surrogates to modulate COX inhibitory activity and selectivity.
  • Nido-carborane structures show promise for developing more potent COX inhibitors.
  • While not outperforming organic analogs, these carborane derivatives represent a step forward in exploring carborane-based NSAIDs.

Related Concept Videos

Inhibition of Cdk Activity 02:34

4.6K

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Substituent Effects on Acidity of Carboxylic Acids 01:31

6.5K

The acidity of carboxylic acids is influenced by the nature of the substituents bounded to the functional group. The acid strength is determined by the stability of the carboxylate anion—the conjugate base formed by dissociating the corresponding carboxylic acid.

Suppose the carboxylic acid bears an electron-withdrawing substituent. In that case, it stabilizes the conjugate base through the electron-withdrawing inductive effect, thereby decreasing the electron density on the carboxylate...

Dose-Response Relationship: Potency and Efficacy 01:22

4.1K

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...

Dose-Response Relationship: Selectivity and Specificity 01:25

6.3K

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...

Conformations of Cycloalkanes 02:29

11.4K

Adolf von Baeyer attempted to explain the instabilities of small and large cycloalkane rings using the concept of angle strain — the strain caused by the deviation of bond angles from the ideal 109.5° tetrahedral value for sp3  hybridized carbons. However, while cyclopropane and cyclobutane are strained, as expected from their highly compressed bond angles, cyclopentane is more strained than predicted, and cyclohexane is virtually strain-free. Hence, Baeyer’s theory that...

Therapeutic Index 01:13

4.0K

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...